Brief: Oryzon Gets Grant Decision In Japan For Iadademstat

ORYZON Genomics SA

22/12/2025 06:47

Dec 22 (Reuters) - Oryzon Genomics SA ORY.MC:

GETS GRANT DECISION IN JAPAN FOR IADADEMSTAT COVERING COMBINATIONS WITH PD-1/PD-L1 INHIBITORS

PATENT IS EXPECTED TO REMAIN IN FORCE UNTIL AT LEAST 2040, EXCLUDING ANY AVAILABLE PATENT TERM EXTENSIONS

Source text: https://tinyurl.com/yv9rajcs

Further company coverage: ORY.MC

 (Gdansk Newsroom)

 ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))